7 JCI-accredited hospitals 17 hospitals with oncology 65 oncology specialists 19 clinical trials recruiting
Oncology & Cancer Care
Prof. Fuat Demirkıran, MD
Gynecologic Oncology

Prof. Fuat Demirkıran, MD

Prof. Fuat Demirkıran, MD is a gynecology & obstetrics specialist at Acibadem Altunizade Hospital. He has more than 50 years of experience in medicine and focuses on ovarian cancer, cervical cancer, endometrial cancer and…

  • Experience50+ years
  • HospitalAltunizade Hospital
  • LanguagesTurkish, English
  • FocusGynecology and obstetrics, Robotic surgery,…

About

Prof. Fuat Demirkıran, MD is a gynecology and obstetrics specialist at Acibadem Altunizade Hospital in İstanbul. With more than 50 years in medicine, his practice combines gynecologic oncology and robotic surgery with urogynecology, menopause care and the assessment of common benign gynecologic conditions.

Dr. Demirkıran studied at İstanbul University İstanbul Faculty of Medicine between 1976 and 1982. His early professional years included positions at the Erzincan State Hospital Surgical Clinic and Surgical Outpatient Clinic in 1982 and at Ilıç Central Health Center from 1984 to 1985. He completed his Obstetrics and Gynecology training at İstanbul University Cerrahpaşa Faculty of Medicine in 1990 and continued to work there in the years that followed, becoming Associate Professor in 1993 and Professor in 1999. In 1995 he undertook clinical studies in gynecologic oncology at University Of Los Angeles California. He joined Acıbadem Healthcare Services in 2002 and completed Gynecologic Oncology Surgery training at İstanbul University Cerrahpaşa Faculty of Medicine in 2011. He is a member of the Gynecologic Oncology Association, the Obstetric and Gynecologic Ultrasonography Association, the Minimally Invasive Surgery Association, ESGO (European Society of Gynecological Oncology), IGCS ( International Gynecologic Cancer Society) and the Turkish Gynecological and Obstetric Association.

Clinical focus

A substantial part of Dr. Demirkıran’s work concerns gynecologic cancers, including ovarian cancer, cervical cancer and endometrial cancer. Robotic surgery is one of his subspecialty areas, and the suitability of a minimally invasive or robotic approach is assessed individually according to the diagnosis, stage and the patient’s overall health. He has co-authored multicenter publications in gynecologic oncology, including Turkish gynecologic oncology group studies on sentinel node biopsy and lymphadenectomy in endometrial cancer, laparoscopic surgery in endometrial cancer, quality indicators for the surgical treatment of cervical cancer, and a phase III trial of maintenance treatment in newly diagnosed ovarian cancer.

He also sees patients with benign and functional gynecologic conditions, including fibroids, polycystic ovary syndrome, menstrual irregularities, ectopic pregnancy and sexually transmitted diseases. His subspecialty interests extend to urogynecology and menopause, where evaluation and care planning are guided by the patient’s symptoms, history and examination findings.

How Dr. Demirkıran works with international patients

Dr. Demirkıran consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the Acibadem international patient team coordinates the collection of prior reports and imaging, such as MRI, CT, X-ray or ultrasound reports, laboratory and pathology results, operative notes and discharge summaries, and arranges appointments and the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the options. Video consultation is available for international patients who wish to discuss their situation before traveling.

Expertise

Conditions treated

  • Ovarian cancer
  • Cervical cancer
  • Endometrial cancer
  • Fibroids
  • Polycystic ovary syndrome
  • Ectopic pregnancy
  • Sexually transmitted diseases
  • Menstrual irregularities

Procedures and treatments

  • Ovarian cancer treatment
  • Cervical cancer treatment
  • Endometrial cancer treatment
  • Polycystic ovary syndrome treatment

Education and career

Timeline

  1. 2011İstanbul University Cerrahpaşa Faculty of Medicine Gynecologic Oncology SurgeryEducation
  2. 2002Acıbadem Healthcare ServicesCareer
  3. 1999İstanbul University Cerrahpaşa Faculty of Medicine / ProfessorEducation
  4. 1999İstanbul University Cerrahpaşa Faculty of MedicineCareer
  5. 1995University Of Los Angeles California Clinical Studies in Gynecologic OncologyCareer
  6. 1995University Of Los AngelesCareer
  7. 1993İstanbul University Cerrahpaşa Faculty of Medicine / Associate ProfessorEducation
  8. 1993İstanbul University Cerrahpaşa Faculty of MedicineCareer
  9. 1992–1993İstanbul University Cerrahpaşa Faculty of MedicineCareer
  10. 1990İstanbul University Cerrahpaşa Faculty of Medicine Obstetrics and GynecologyEducation
  11. 1990–1991İstanbul University Cerrahpaşa Faculty of MedicineCareer
  12. 1984–1985Ilıç Central Health CenterCareer
  13. 1982Erzincan State Hospital Surgical Outpatient ClinicCareer
  14. 1982Erzincan State Hospital Surgical ClinicCareer
  15. 1976–1982İstanbul University İstanbul Faculty of MedicineEducation

Memberships

  • Gynecologic Oncology Association
  • Obstetric and Gynecologic Ultrasonography Association
  • Minimally Invasive Surgery Association
  • ESGO (European Society of Gynecological Oncology)
  • IGCS ( International Gynecologic Cancer Society)
  • Turkish Gynecological and Obstetric Association

Tumour boards

Cancer types where Prof. Fuat Demirkıran, MD is part of the specialist team

This page is general information from Acıbadem oncology teams and does not replace a consultation. Treatment decisions are made after a review of your reports by a tumour board.

Second opinion · Free case review

Send your reports and get a plan from a tumour board, not a single doctor

Pathology, imaging and previous treatment history are enough to start. Written recommendation within 48 hours, including trial eligibility.